Key Statistics
Market Cap$8.24M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$17.85
52W High$9.25
52W Low$3.91
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees23
Price Performance
1 Week-2.05%
3 Month-24.20%
1 Year-45.75%
FinancialsAnnual · QuiverQuant
Revenue$7.88M
Assets$159.78M
Liabilities$47.04M
Net Income$69.20M loss
About
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze BOLT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.
